chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysphonia, Pruritus, Urticaria
Clinical narrative: We had an adverse reaction to a Moderna vaccine today. Someone was notified. The patient received her vaccine around 6:55 pm on Saturday 4.10.21. She had a history of allergies but no anaphylaxis, or even hives. I felt comfortable giving her the vaccine with her history.  Around 7 pm, her husband came to the counter and said she was itching a lot. I brought her to the immunization room and asked if she was interested in taking Benadryl. She was so I gave her two diphenhydramine tablets, 50 mg total. After 20 minutes, she started having hives and the husband requested we give her liquid Benadryl. I provided another 25 mg in liquid at 7:20 pm and 7:30 pm. At 7:30 I also provided her hydrocortisone 1% cream over the counter to help with the itching.  At 7:30 she requested to go home but I did not feel comfortable letting her go so I asked her to wait a little longer. I had her husband stay with her and at 7:55 pm I heard hoarseness in her voice. At that point I took out the epinephrine and she didn't want it, I said I had to give it to her on the account that she was getting worse and I would have to call EMS.  I administered one epinephrine pen and she instantaneously was able to breath again. EMS arrived within minutes and assessed the patient. EMS confirmed that she was doing well and the medications that were provided were appropriate and kept her symptoms at bay. EMS checked her BP, HR and did an EKG and it all checked out and patient was doing well. At no point did she lose consciousness.     She was asked if she wanted to go to the ER or return home and she was comfortable going home.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Back pain, Guillain-Barre syndrome, Hypoaesthesia, Hypoaesthesia oral, Paraesthesia
Clinical narrative: Feet, legs, arms, hands, lower face and tongue all tingly and numb; severe back pain
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Back pain, Blood test, CSF protein increased, Chest X-ray, Computerised tomogram
Clinical narrative: Feet, legs, arms, hands, lower face and tongue all tingly and numb; severe back pain
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Electromyogram, Hypoaesthesia, Lumbar puncture abnormal, Magnetic resonance imaging head, Magnetic resonance imaging neck
Clinical narrative: Feet, legs, arms, hands, lower face and tongue all tingly and numb; severe back pain
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging thoracic, Paraesthesia, Paraesthesia oral
Clinical narrative: Feet, legs, arms, hands, lower face and tongue all tingly and numb; severe back pain
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Diarrhoea, Dizziness, Vomiting
Clinical narrative: Relapsing MS 4 days hospitalized  6 rounds of steroids  4 visits to neurologist  Dizziness  Diarrhea  Vomiting  Confusion  Unstable walking
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Computerised tomogram, Confusional state, Diarrhoea, Dizziness
Clinical narrative: Relapsing MS 4 days hospitalized  6 rounds of steroids  4 visits to neurologist  Dizziness  Diarrhea  Vomiting  Confusion  Unstable walking
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Gait disturbance, Laboratory test, Magnetic resonance imaging, Relapsing multiple sclerosis, Vomiting
Clinical narrative: Relapsing MS 4 days hospitalized  6 rounds of steroids  4 visits to neurologist  Dizziness  Diarrhea  Vomiting  Confusion  Unstable walking
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Brain injury, Cardiac arrest, Computerised tomogram thorax abnormal, Deep vein thrombosis, Dyspnoea
Clinical narrative: PEA Cardiac Arrest tx with intubation, CPR, Epi prolonged mechanical ventilation, vasopressors, IVC filter, PEG, Trach.  Now off of mechanical ventilation but still vented
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea exertional, Peripheral swelling, Ultrasound scan abnormal
Clinical narrative: PEA Cardiac Arrest tx with intubation, CPR, Epi prolonged mechanical ventilation, vasopressors, IVC filter, PEG, Trach.  Now off of mechanical ventilation but still vented
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angiogram pulmonary abnormal, Brain injury, Cardiac arrest, Deep vein thrombosis, Endotracheal intubation
Clinical narrative: PEA Cardiac Arrest tx with intubation, CPR, Epi prolonged mechanical ventilation, vasopressors, IVC filter, PEG, Trach.  Now off of mechanical ventilation but still vented
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Gastrostomy, Heparin-induced thrombocytopenia test positive, Magnetic resonance imaging head abnormal, Mechanical ventilation, Platelet count decreased
Clinical narrative: PEA Cardiac Arrest tx with intubation, CPR, Epi prolonged mechanical ventilation, vasopressors, IVC filter, PEG, Trach.  Now off of mechanical ventilation but still vented
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pulmonary embolism, Pulseless electrical activity, Resuscitation, Tracheostomy, Ultrasound Doppler abnormal
Clinical narrative: PEA Cardiac Arrest tx with intubation, CPR, Epi prolonged mechanical ventilation, vasopressors, IVC filter, PEG, Trach.  Now off of mechanical ventilation but still vented
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vena cava filter insertion
Clinical narrative: PEA Cardiac Arrest tx with intubation, CPR, Epi prolonged mechanical ventilation, vasopressors, IVC filter, PEG, Trach.  Now off of mechanical ventilation but still vented
Age: 36.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Condition aggravated, Injection site erythema, Injection site mass, Injection site pain, Injection site pruritus
Clinical narrative: Patient called GPH on 4/21/21 to report her symptoms after her first vaccine dose. She received her first Moderna vaccine 4/1/21 around 1400. within 30 minutes her arm felt hard and hot to touch; this lasted 3 days. On Wednesday 4/7/21 she developed "COVID arm." At the injection site on her left arm she developed redness and swelling, every day it "traveled about 3 inches." She reports measuring it at 10 1/2 inches by 8 inches of redness and swelling.  Swelling went down to her left arm to her hand and up to the left side of her neck and throat.  She saw her doctor she "cannot remember the appointment date" but was placed on a 5-day course of prednisone and is advised by her doctor not to receive her second dose.
Age: 36.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Injection site warmth, Lymphadenopathy, Mobility decreased, Peripheral swelling, Rash macular
Clinical narrative: Patient called GPH on 4/21/21 to report her symptoms after her first vaccine dose. She received her first Moderna vaccine 4/1/21 around 1400. within 30 minutes her arm felt hard and hot to touch; this lasted 3 days. On Wednesday 4/7/21 she developed "COVID arm." At the injection site on her left arm she developed redness and swelling, every day it "traveled about 3 inches." She reports measuring it at 10 1/2 inches by 8 inches of redness and swelling.  Swelling went down to her left arm to her hand and up to the left side of her neck and throat.  She saw her doctor she "cannot remember the appointment date" but was placed on a 5-day course of prednisone and is advised by her doctor not to receive her second dose.
Age: 36.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Erythema, Induration, Injection site erythema, Injection site swelling, Peripheral swelling
Clinical narrative: Patient called GPH on 4/21/21 to report her symptoms after her first vaccine dose. She received her first Moderna vaccine 4/1/21 around 1400. within 30 minutes her arm felt hard and hot to touch; this lasted 3 days. On Wednesday 4/7/21 she developed "COVID arm." At the injection site on her left arm she developed redness and swelling, every day it "traveled about 3 inches." She reports measuring it at 10 1/2 inches by 8 inches of redness and swelling.  Swelling went down to her left arm to her hand and up to the left side of her neck and throat.  She saw her doctor she "cannot remember the appointment date" but was placed on a 5-day course of prednisone and is advised by her doctor not to receive her second dose.
Age: 36.0
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Pharyngeal swelling, Swelling
Clinical narrative: Patient called GPH on 4/21/21 to report her symptoms after her first vaccine dose. She received her first Moderna vaccine 4/1/21 around 1400. within 30 minutes her arm felt hard and hot to touch; this lasted 3 days. On Wednesday 4/7/21 she developed "COVID arm." At the injection site on her left arm she developed redness and swelling, every day it "traveled about 3 inches." She reports measuring it at 10 1/2 inches by 8 inches of redness and swelling.  Swelling went down to her left arm to her hand and up to the left side of her neck and throat.  She saw her doctor she "cannot remember the appointment date" but was placed on a 5-day course of prednisone and is advised by her doctor not to receive her second dose.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Full blood count abnormal, Headache, Nausea, Pain in extremity, Platelet count decreased
Clinical narrative: Subarachnoid hemorrhage - significant in nature. Requiring prolonged hospitalization and currently persistent neurologic deficits profound in nature
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, Subarachnoid haemorrhage, Surgery
Clinical narrative: Subarachnoid hemorrhage - significant in nature. Requiring prolonged hospitalization and currently persistent neurologic deficits profound in nature
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angiogram cerebral abnormal, Computerised tomogram head, Computerised tomogram head abnormal, Intra-cerebral aneurysm operation, Nervous system disorder
Clinical narrative: Subarachnoid hemorrhage - significant in nature. Requiring prolonged hospitalization and currently persistent neurologic deficits profound in nature
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Subarachnoid haemorrhage
Clinical narrative: Subarachnoid hemorrhage - significant in nature. Requiring prolonged hospitalization and currently persistent neurologic deficits profound in nature
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Deep vein thrombosis, Peripheral swelling, Ultrasound scan
Clinical narrative: DVT in right leg from calf to thigh; small blood clots; swollen right leg; This is a spontaneous report from a contactable consumer (patient).  A 69-year-old  male patient received bnt162b2 (BNT162B2; lot unknown: Not available/provided to reporter at the time of report completion), dose 1 via an unspecified route of administration, administered in Arm Left on 20Jan2021 14:00 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunization, at the age at vaccination of 68 years old.  Medical history included high blood pressure from an unknown date and unknown if ongoing. No other vaccine in four weeks. Patient had no known allergies. Concomitant medications included losartan taken for an unspecified indication, start and stop date were not reported.  The patient experienced dvt in right leg from calf to thigh on 25Jan2021 with outcome of not recovered, small blood clots on 25Jan2021 with outcome of not recovered, swollen right leg on 24Jan2021 10:00 AM with outcome of not recovered. Reported four days after the first vaccine, swollen right leg. Five days after the first vaccine, diagnosed with DVT in right leg from calf to thigh. Small blood clots. Events resulted in: Doctor or other healthcare professional office/clinic visit, Life threatening illness (immediate risk of death from the event). No Covid prior vaccination. No Covid tested post vaccination. Therapeutic measures were taken as a result of events included: Eliquis.   Information on the lot/batch number has been requested.
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Deep vein thrombosis, Peripheral swelling, Thrombosis
Clinical narrative: DVT in right leg from calf to thigh; small blood clots; swollen right leg; This is a spontaneous report from a contactable consumer (patient).  A 69-year-old  male patient received bnt162b2 (BNT162B2; lot unknown: Not available/provided to reporter at the time of report completion), dose 1 via an unspecified route of administration, administered in Arm Left on 20Jan2021 14:00 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunization, at the age at vaccination of 68 years old.  Medical history included high blood pressure from an unknown date and unknown if ongoing. No other vaccine in four weeks. Patient had no known allergies. Concomitant medications included losartan taken for an unspecified indication, start and stop date were not reported.  The patient experienced dvt in right leg from calf to thigh on 25Jan2021 with outcome of not recovered, small blood clots on 25Jan2021 with outcome of not recovered, swollen right leg on 24Jan2021 10:00 AM with outcome of not recovered. Reported four days after the first vaccine, swollen right leg. Five days after the first vaccine, diagnosed with DVT in right leg from calf to thigh. Small blood clots. Events resulted in: Doctor or other healthcare professional office/clinic visit, Life threatening illness (immediate risk of death from the event). No Covid prior vaccination. No Covid tested post vaccination. Therapeutic measures were taken as a result of events included: Eliquis.   Information on the lot/batch number has been requested.
Sex: U
Vaccine: COVID19, COVID19, COVID19
Symptoms: Back pain, Chest pain, Chills, Dyspnoea, Pain
Clinical narrative: BLOOD CLOTS IN MY LEFT LUNG; GOT SERIOUSLY SICK; This spontaneous report received from a patient via a company representative and concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.  The patient received Janssen COVID-19 Vaccine (ad26.cov2.s) (suspension for injection, intramuscular, batch number: Unknown) dose was not reported, administered on 20-MAR-2021 for prophylactic vaccination. The batch number was not reported, and has been requested. No concomitant medications were reported.  On an unspecified date, the patient got seriously sick and was hospitalized for blood clots in left lung on unspecified date. Patient reported blood clots in left lung that caused to be hospitalized for two days. Patient reported being on blood thinners (unspecified) and oxygen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the got seriously sick and blood clots in my left lung was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: A patient of unspecified age and sex experienced blood clots in the left lung an unspecified time after vaccine. The patient reported being on blood thinners and oxygen. No further details were provided. There is insufficient information to make a meaningful medical assessment. Additional information has been requested.
Sex: U
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pulmonary embolism, Pyrexia
Clinical narrative: BLOOD CLOTS IN MY LEFT LUNG; GOT SERIOUSLY SICK; This spontaneous report received from a patient via a company representative and concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.  The patient received Janssen COVID-19 Vaccine (ad26.cov2.s) (suspension for injection, intramuscular, batch number: Unknown) dose was not reported, administered on 20-MAR-2021 for prophylactic vaccination. The batch number was not reported, and has been requested. No concomitant medications were reported.  On an unspecified date, the patient got seriously sick and was hospitalized for blood clots in left lung on unspecified date. Patient reported blood clots in left lung that caused to be hospitalized for two days. Patient reported being on blood thinners (unspecified) and oxygen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the got seriously sick and blood clots in my left lung was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: A patient of unspecified age and sex experienced blood clots in the left lung an unspecified time after vaccine. The patient reported being on blood thinners and oxygen. No further details were provided. There is insufficient information to make a meaningful medical assessment. Additional information has been requested.
Sex: U
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pulmonary thrombosis
Clinical narrative: BLOOD CLOTS IN MY LEFT LUNG; GOT SERIOUSLY SICK; This spontaneous report received from a patient via a company representative and concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.  The patient received Janssen COVID-19 Vaccine (ad26.cov2.s) (suspension for injection, intramuscular, batch number: Unknown) dose was not reported, administered on 20-MAR-2021 for prophylactic vaccination. The batch number was not reported, and has been requested. No concomitant medications were reported.  On an unspecified date, the patient got seriously sick and was hospitalized for blood clots in left lung on unspecified date. Patient reported blood clots in left lung that caused to be hospitalized for two days. Patient reported being on blood thinners (unspecified) and oxygen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the got seriously sick and blood clots in my left lung was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: A patient of unspecified age and sex experienced blood clots in the left lung an unspecified time after vaccine. The patient reported being on blood thinners and oxygen. No further details were provided. There is insufficient information to make a meaningful medical assessment. Additional information has been requested.
Sex: U
Vaccine: COVID19, COVID19, COVID19
Symptoms: Illness, Pulmonary thrombosis
Clinical narrative: BLOOD CLOTS IN MY LEFT LUNG; GOT SERIOUSLY SICK; This spontaneous report received from a patient via a company representative and concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.  The patient received Janssen COVID-19 Vaccine (ad26.cov2.s) (suspension for injection, intramuscular, batch number: Unknown) dose was not reported, administered on 20-MAR-2021 for prophylactic vaccination. The batch number was not reported, and has been requested. No concomitant medications were reported.  On an unspecified date, the patient got seriously sick and was hospitalized for blood clots in left lung on unspecified date. Patient reported blood clots in left lung that caused to be hospitalized for two days. Patient reported being on blood thinners (unspecified) and oxygen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the got seriously sick and blood clots in my left lung was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: A patient of unspecified age and sex experienced blood clots in the left lung an unspecified time after vaccine. The patient reported being on blood thinners and oxygen. No further details were provided. There is insufficient information to make a meaningful medical assessment. Additional information has been requested.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Flushing, Oropharyngeal pain, Paraesthesia oral, Periorbital swelling
Clinical narrative: SORE THROAT; SWOLLEN FACE; TINGLING LIPS; FATIGUE; FLUSHED FACE; This spontaneous report received from a patient concerned a 60 year old female. The patient's height, and weight were not reported.  The patient's concurrent conditions included obstructive sleep apnea, hbp, bipap at night, non-smoker, abstains from alcohol, and seasonal allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose was not reported, administered on 11-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. Concomitant medications included colecalciferol for drug used for unknown indication, duloxetine hydrochloride for drug used for unknown indication, hydrochlorothiazide/triamterene for drug used for unknown indication, loratadine for drug used for unknown indication, metoprolol for drug used for unknown indication, orlistat for drug used for unknown indication, and paracetamol.  On 12-APR-2021, the subject experienced flushed face. On 12-APR-2021, the subject experienced fatigue. On 13-APR-2021, the subject experienced swollen face. On 13-APR-2021, the subject experienced tingling lips. On 14-APR-2021, the subject experienced sore throat. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from swollen face, tingling lips, and fatigue on 13-APR-2021, was recovering from flushed face, and had not recovered from sore throat. This report was non-serious.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Swelling face
Clinical narrative: SORE THROAT; SWOLLEN FACE; TINGLING LIPS; FATIGUE; FLUSHED FACE; This spontaneous report received from a patient concerned a 60 year old female. The patient's height, and weight were not reported.  The patient's concurrent conditions included obstructive sleep apnea, hbp, bipap at night, non-smoker, abstains from alcohol, and seasonal allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose was not reported, administered on 11-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. Concomitant medications included colecalciferol for drug used for unknown indication, duloxetine hydrochloride for drug used for unknown indication, hydrochlorothiazide/triamterene for drug used for unknown indication, loratadine for drug used for unknown indication, metoprolol for drug used for unknown indication, orlistat for drug used for unknown indication, and paracetamol.  On 12-APR-2021, the subject experienced flushed face. On 12-APR-2021, the subject experienced fatigue. On 13-APR-2021, the subject experienced swollen face. On 13-APR-2021, the subject experienced tingling lips. On 14-APR-2021, the subject experienced sore throat. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from swollen face, tingling lips, and fatigue on 13-APR-2021, was recovering from flushed face, and had not recovered from sore throat. This report was non-serious.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Flushing, Oropharyngeal pain, Paraesthesia oral, Swelling face
Clinical narrative: SORE THROAT; SWOLLEN FACE; TINGLING LIPS; FATIGUE; FLUSHED FACE; This spontaneous report received from a patient concerned a 60 year old female. The patient's height, and weight were not reported.  The patient's concurrent conditions included obstructive sleep apnea, hbp, bipap at night, non-smoker, abstains from alcohol, and seasonal allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose was not reported, administered on 11-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. Concomitant medications included colecalciferol for drug used for unknown indication, duloxetine hydrochloride for drug used for unknown indication, hydrochlorothiazide/triamterene for drug used for unknown indication, loratadine for drug used for unknown indication, metoprolol for drug used for unknown indication, orlistat for drug used for unknown indication, and paracetamol.  On 12-APR-2021, the subject experienced flushed face. On 12-APR-2021, the subject experienced fatigue. On 13-APR-2021, the subject experienced swollen face. On 13-APR-2021, the subject experienced tingling lips. On 14-APR-2021, the subject experienced sore throat. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from swollen face, tingling lips, and fatigue on 13-APR-2021, was recovering from flushed face, and had not recovered from sore throat. This report was non-serious.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Angiogram, Fibrin D dimer, Full blood count, Heavy menstrual bleeding, Metabolic function test
Clinical narrative: Acute ITP -Platelet 2K on admission, previously 279K in Feb 2021 - Reports receiving J&J COVID vaccine 1 month prior - s/p 2 units platelet transfusion (4/9 and 4/10) - s/p IVIG x 4 days - Continue Prednisone taper (80mg daily for 2 more days, then 60mg daily until follows up with Hematology and repeat CBC).  - Plan to follow-up with PCP doctor on 4/16 and Hematology doctor on 4/19
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Petechiae, Platelet count decreased, Troponin
Clinical narrative: Acute ITP -Platelet 2K on admission, previously 279K in Feb 2021 - Reports receiving J&J COVID vaccine 1 month prior - s/p 2 units platelet transfusion (4/9 and 4/10) - s/p IVIG x 4 days - Continue Prednisone taper (80mg daily for 2 more days, then 60mg daily until follows up with Hematology and repeat CBC).  - Plan to follow-up with PCP doctor on 4/16 and Hematology doctor on 4/19
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Immune thrombocytopenia, Immunoglobulin therapy, Platelet count decreased, Platelet transfusion
Clinical narrative: Acute ITP -Platelet 2K on admission, previously 279K in Feb 2021 - Reports receiving J&J COVID vaccine 1 month prior - s/p 2 units platelet transfusion (4/9 and 4/10) - s/p IVIG x 4 days - Continue Prednisone taper (80mg daily for 2 more days, then 60mg daily until follows up with Hematology and repeat CBC).  - Plan to follow-up with PCP doctor on 4/16 and Hematology doctor on 4/19
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site rash, Injection site swelling
Clinical narrative: INJECTION SITE REACTION (INJECTION SITE HAS A RASH, IT IS ITCHY, SWELLING PAIN AND HOT TO THE TOUCH); HAD BODY ACHES; HEADACHE; FELT TIRED; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced injection site reaction (injection site has a rash, it is itchy, swelling pain and hot to the touch), had body aches, headache, and felt tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headache, injection site reaction (injection site has a rash, it is itchy, swelling pain and hot to the touch), felt tired and had body aches was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site warmth, Skin irritation
Clinical narrative: INJECTION SITE REACTION (INJECTION SITE HAS A RASH, IT IS ITCHY, SWELLING PAIN AND HOT TO THE TOUCH); HAD BODY ACHES; HEADACHE; FELT TIRED; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced injection site reaction (injection site has a rash, it is itchy, swelling pain and hot to the touch), had body aches, headache, and felt tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headache, injection site reaction (injection site has a rash, it is itchy, swelling pain and hot to the touch), felt tired and had body aches was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Headache, Injection site reaction, Pain
Clinical narrative: INJECTION SITE REACTION (INJECTION SITE HAS A RASH, IT IS ITCHY, SWELLING PAIN AND HOT TO THE TOUCH); HAD BODY ACHES; HEADACHE; FELT TIRED; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced injection site reaction (injection site has a rash, it is itchy, swelling pain and hot to the touch), had body aches, headache, and felt tired. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the headache, injection site reaction (injection site has a rash, it is itchy, swelling pain and hot to the touch), felt tired and had body aches was not reported. This report was non-serious.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anaphylactic reaction, Condition aggravated, Cough, Diarrhoea, Dysphagia
Clinical narrative: throat and tongue started swelling again and were very itchy; throat and tongue started swelling again and were very itchy; difficulty breathing; swallowing saliva; wheezing; noticeably lower than usual with a HR of ~60, BP of 100/70; feeling extreme itchiness and swelling in my tongue; itchiness in her tongue/throat and tongue started were very itchy/feeling extreme itchiness and swelling in her tongue; slight headache/ Headache got worse; felt fatigued; voice sounded weird/my throat was extremely hoarse; constantly cough; upset diarrhea; This is a spontaneous report from a contactable consumer (patient). A 34-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose via an unspecified route of administration, administered in arm left on 31Mar2021 16:45 at age of 34-year-old (Batch/Lot Number: ER8732) at single dose for COVID-19 immunization.  Medical history included Von Willebrands Type 1, and a family history of auto-immune issues like myasthenia gravis, lupus and Chronic inflammatory demyelinating polyradiculoneuropathy. Patient had known allergies to coconut, latex. Concomitant medications included norethindrone acetate and ethinyl estradiol. There was no other vaccine in four weeks. On 01Apr2021, the patient woke up at 08:00 with slight headache and felt fatigued but most noticeably her voice sounded weird and her throat was extremely hoarse while talking in work meeting and she had to constantly cough to clear it. Headache got worse in the afternoon and she had upset diarrhea. Around 19:45 she started feeling extreme itchiness and swelling in her tongue. This didn't improve, so she took 25mg diphenhydramine hydrochloride (BENADRYL)  at 20:20, at which time her vitals were normal, but noticeably lower than usual with a heart rate of 60, blood pressure of 100/70, O2 sat 99% and normal temperature. She also took another 1000 mg paracetamol (TYLENOL) at 21:30 and went to bed. 02Apr2021, 07: 30 woke up and her throat and tongue started swelling again and were very itchy. She then began had difficulty breathing and swallowing saliva. She also could not swallow a banana easily, stopped eating it. She also had some wheezing that would only go away with a cough. She took 25mg more of diphenhydramine hydrochloride and went to urgent care immediately because breathing was becoming increasingly difficult. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, life threatening illness (immediate risk of death from the event). Treatment for the events included diphenhydramine hydrochloride injection and prednisone. There was no COVID prior vaccination. There was no COVID tested post vaccination. The patient recovered from the events in Apr2021.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysphonia, Dyspnoea, Fatigue, Headache, Pharyngeal swelling
Clinical narrative: throat and tongue started swelling again and were very itchy; throat and tongue started swelling again and were very itchy; difficulty breathing; swallowing saliva; wheezing; noticeably lower than usual with a HR of ~60, BP of 100/70; feeling extreme itchiness and swelling in my tongue; itchiness in her tongue/throat and tongue started were very itchy/feeling extreme itchiness and swelling in her tongue; slight headache/ Headache got worse; felt fatigued; voice sounded weird/my throat was extremely hoarse; constantly cough; upset diarrhea; This is a spontaneous report from a contactable consumer (patient). A 34-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose via an unspecified route of administration, administered in arm left on 31Mar2021 16:45 at age of 34-year-old (Batch/Lot Number: ER8732) at single dose for COVID-19 immunization.  Medical history included Von Willebrands Type 1, and a family history of auto-immune issues like myasthenia gravis, lupus and Chronic inflammatory demyelinating polyradiculoneuropathy. Patient had known allergies to coconut, latex. Concomitant medications included norethindrone acetate and ethinyl estradiol. There was no other vaccine in four weeks. On 01Apr2021, the patient woke up at 08:00 with slight headache and felt fatigued but most noticeably her voice sounded weird and her throat was extremely hoarse while talking in work meeting and she had to constantly cough to clear it. Headache got worse in the afternoon and she had upset diarrhea. Around 19:45 she started feeling extreme itchiness and swelling in her tongue. This didn't improve, so she took 25mg diphenhydramine hydrochloride (BENADRYL)  at 20:20, at which time her vitals were normal, but noticeably lower than usual with a heart rate of 60, blood pressure of 100/70, O2 sat 99% and normal temperature. She also took another 1000 mg paracetamol (TYLENOL) at 21:30 and went to bed. 02Apr2021, 07: 30 woke up and her throat and tongue started swelling again and were very itchy. She then began had difficulty breathing and swallowing saliva. She also could not swallow a banana easily, stopped eating it. She also had some wheezing that would only go away with a cough. She took 25mg more of diphenhydramine hydrochloride and went to urgent care immediately because breathing was becoming increasingly difficult. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, life threatening illness (immediate risk of death from the event). Treatment for the events included diphenhydramine hydrochloride injection and prednisone. There was no COVID prior vaccination. There was no COVID tested post vaccination. The patient recovered from the events in Apr2021.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Swollen tongue, Throat irritation, Tongue pruritus, Wheezing
Clinical narrative: throat and tongue started swelling again and were very itchy; throat and tongue started swelling again and were very itchy; difficulty breathing; swallowing saliva; wheezing; noticeably lower than usual with a HR of ~60, BP of 100/70; feeling extreme itchiness and swelling in my tongue; itchiness in her tongue/throat and tongue started were very itchy/feeling extreme itchiness and swelling in her tongue; slight headache/ Headache got worse; felt fatigued; voice sounded weird/my throat was extremely hoarse; constantly cough; upset diarrhea; This is a spontaneous report from a contactable consumer (patient). A 34-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose via an unspecified route of administration, administered in arm left on 31Mar2021 16:45 at age of 34-year-old (Batch/Lot Number: ER8732) at single dose for COVID-19 immunization.  Medical history included Von Willebrands Type 1, and a family history of auto-immune issues like myasthenia gravis, lupus and Chronic inflammatory demyelinating polyradiculoneuropathy. Patient had known allergies to coconut, latex. Concomitant medications included norethindrone acetate and ethinyl estradiol. There was no other vaccine in four weeks. On 01Apr2021, the patient woke up at 08:00 with slight headache and felt fatigued but most noticeably her voice sounded weird and her throat was extremely hoarse while talking in work meeting and she had to constantly cough to clear it. Headache got worse in the afternoon and she had upset diarrhea. Around 19:45 she started feeling extreme itchiness and swelling in her tongue. This didn't improve, so she took 25mg diphenhydramine hydrochloride (BENADRYL)  at 20:20, at which time her vitals were normal, but noticeably lower than usual with a heart rate of 60, blood pressure of 100/70, O2 sat 99% and normal temperature. She also took another 1000 mg paracetamol (TYLENOL) at 21:30 and went to bed. 02Apr2021, 07: 30 woke up and her throat and tongue started swelling again and were very itchy. She then began had difficulty breathing and swallowing saliva. She also could not swallow a banana easily, stopped eating it. She also had some wheezing that would only go away with a cough. She took 25mg more of diphenhydramine hydrochloride and went to urgent care immediately because breathing was becoming increasingly difficult. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, life threatening illness (immediate risk of death from the event). Treatment for the events included diphenhydramine hydrochloride injection and prednisone. There was no COVID prior vaccination. There was no COVID tested post vaccination. The patient recovered from the events in Apr2021.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure measurement, Body temperature, Cough, Diarrhoea, Dysphagia
Clinical narrative: throat and tongue started swelling again and were very itchy; throat and tongue started swelling again and were very itchy; difficulty breathing; swallowing saliva; wheezing; noticeably lower than usual with a HR of ~60, BP of 100/70; feeling extreme itchiness and swelling in my tongue; itchiness in her tongue/throat and tongue started were very itchy/feeling extreme itchiness and swelling in her tongue; slight headache/ Headache got worse; felt fatigued; voice sounded weird/my throat was extremely hoarse; constantly cough; upset diarrhea; This is a spontaneous report from a contactable consumer (patient). A 34-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose via an unspecified route of administration, administered in arm left on 31Mar2021 16:45 at age of 34-year-old (Batch/Lot Number: ER8732) at single dose for COVID-19 immunization.  Medical history included Von Willebrands Type 1, and a family history of auto-immune issues like myasthenia gravis, lupus and Chronic inflammatory demyelinating polyradiculoneuropathy. Patient had known allergies to coconut, latex. Concomitant medications included norethindrone acetate and ethinyl estradiol. There was no other vaccine in four weeks. On 01Apr2021, the patient woke up at 08:00 with slight headache and felt fatigued but most noticeably her voice sounded weird and her throat was extremely hoarse while talking in work meeting and she had to constantly cough to clear it. Headache got worse in the afternoon and she had upset diarrhea. Around 19:45 she started feeling extreme itchiness and swelling in her tongue. This didn't improve, so she took 25mg diphenhydramine hydrochloride (BENADRYL)  at 20:20, at which time her vitals were normal, but noticeably lower than usual with a heart rate of 60, blood pressure of 100/70, O2 sat 99% and normal temperature. She also took another 1000 mg paracetamol (TYLENOL) at 21:30 and went to bed. 02Apr2021, 07: 30 woke up and her throat and tongue started swelling again and were very itchy. She then began had difficulty breathing and swallowing saliva. She also could not swallow a banana easily, stopped eating it. She also had some wheezing that would only go away with a cough. She took 25mg more of diphenhydramine hydrochloride and went to urgent care immediately because breathing was becoming increasingly difficult. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, life threatening illness (immediate risk of death from the event). Treatment for the events included diphenhydramine hydrochloride injection and prednisone. There was no COVID prior vaccination. There was no COVID tested post vaccination. The patient recovered from the events in Apr2021.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysphonia, Dyspnoea, Fatigue, Headache, Heart rate
Clinical narrative: throat and tongue started swelling again and were very itchy; throat and tongue started swelling again and were very itchy; difficulty breathing; swallowing saliva; wheezing; noticeably lower than usual with a HR of ~60, BP of 100/70; feeling extreme itchiness and swelling in my tongue; itchiness in her tongue/throat and tongue started were very itchy/feeling extreme itchiness and swelling in her tongue; slight headache/ Headache got worse; felt fatigued; voice sounded weird/my throat was extremely hoarse; constantly cough; upset diarrhea; This is a spontaneous report from a contactable consumer (patient). A 34-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose via an unspecified route of administration, administered in arm left on 31Mar2021 16:45 at age of 34-year-old (Batch/Lot Number: ER8732) at single dose for COVID-19 immunization.  Medical history included Von Willebrands Type 1, and a family history of auto-immune issues like myasthenia gravis, lupus and Chronic inflammatory demyelinating polyradiculoneuropathy. Patient had known allergies to coconut, latex. Concomitant medications included norethindrone acetate and ethinyl estradiol. There was no other vaccine in four weeks. On 01Apr2021, the patient woke up at 08:00 with slight headache and felt fatigued but most noticeably her voice sounded weird and her throat was extremely hoarse while talking in work meeting and she had to constantly cough to clear it. Headache got worse in the afternoon and she had upset diarrhea. Around 19:45 she started feeling extreme itchiness and swelling in her tongue. This didn't improve, so she took 25mg diphenhydramine hydrochloride (BENADRYL)  at 20:20, at which time her vitals were normal, but noticeably lower than usual with a heart rate of 60, blood pressure of 100/70, O2 sat 99% and normal temperature. She also took another 1000 mg paracetamol (TYLENOL) at 21:30 and went to bed. 02Apr2021, 07: 30 woke up and her throat and tongue started swelling again and were very itchy. She then began had difficulty breathing and swallowing saliva. She also could not swallow a banana easily, stopped eating it. She also had some wheezing that would only go away with a cough. She took 25mg more of diphenhydramine hydrochloride and went to urgent care immediately because breathing was becoming increasingly difficult. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, life threatening illness (immediate risk of death from the event). Treatment for the events included diphenhydramine hydrochloride injection and prednisone. There was no COVID prior vaccination. There was no COVID tested post vaccination. The patient recovered from the events in Apr2021.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Heart rate decreased, Oxygen saturation, Pharyngeal swelling, Swollen tongue, Throat irritation
Clinical narrative: throat and tongue started swelling again and were very itchy; throat and tongue started swelling again and were very itchy; difficulty breathing; swallowing saliva; wheezing; noticeably lower than usual with a HR of ~60, BP of 100/70; feeling extreme itchiness and swelling in my tongue; itchiness in her tongue/throat and tongue started were very itchy/feeling extreme itchiness and swelling in her tongue; slight headache/ Headache got worse; felt fatigued; voice sounded weird/my throat was extremely hoarse; constantly cough; upset diarrhea; This is a spontaneous report from a contactable consumer (patient). A 34-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), first dose via an unspecified route of administration, administered in arm left on 31Mar2021 16:45 at age of 34-year-old (Batch/Lot Number: ER8732) at single dose for COVID-19 immunization.  Medical history included Von Willebrands Type 1, and a family history of auto-immune issues like myasthenia gravis, lupus and Chronic inflammatory demyelinating polyradiculoneuropathy. Patient had known allergies to coconut, latex. Concomitant medications included norethindrone acetate and ethinyl estradiol. There was no other vaccine in four weeks. On 01Apr2021, the patient woke up at 08:00 with slight headache and felt fatigued but most noticeably her voice sounded weird and her throat was extremely hoarse while talking in work meeting and she had to constantly cough to clear it. Headache got worse in the afternoon and she had upset diarrhea. Around 19:45 she started feeling extreme itchiness and swelling in her tongue. This didn't improve, so she took 25mg diphenhydramine hydrochloride (BENADRYL)  at 20:20, at which time her vitals were normal, but noticeably lower than usual with a heart rate of 60, blood pressure of 100/70, O2 sat 99% and normal temperature. She also took another 1000 mg paracetamol (TYLENOL) at 21:30 and went to bed. 02Apr2021, 07: 30 woke up and her throat and tongue started swelling again and were very itchy. She then began had difficulty breathing and swallowing saliva. She also could not swallow a banana easily, stopped eating it. She also had some wheezing that would only go away with a cough. She took 25mg more of diphenhydramine hydrochloride and went to urgent care immediately because breathing was becoming increasingly difficult. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, life threatening illness (immediate risk of death from the event). Treatment for the events included diphenhydramine hydrochloride injection and prednisone. There was no COVID prior vaccination. There was no COVID tested post vaccination. The patient recovered from the events in Apr2021.